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Introduction
Both vision and hearing loss are common age-related conditions, associated with poor health outcomes, including functional disability, depression and cognitive decline [1] [2] [3] [4] [5] [6] [7] [8] [9] . Numerous studies in diverse populations suggest sensory impairments (SI) are predictors of decreased survival, independent of other traditional mortality risk factors such as hypertension and diabetes [10] [11] [12] [13] [14] [15] [16] [17] . However, data from the UK [18] and Australia [19] indicate that the association between visual impairment and mortality reflects concomitant morbidities. Similarly, an association between hearing impairment (HI) and mortality in the Blue Mountains Hearing study [20] became non-significant after adjustment for risk factors. Analyses linking data from the National Health Interview Survey with the National Death Index in the USA suggested that deaf participants experienced decreased survival, but this finding was attributed to their lower self-reported health status [21] . The joint effects of SI on health outcomes, including mortality risk, have not been investigated fully, particularly when compared with a single impairment [14] .
As the population ages, the prevalence of hearing and visual impairments is expected to increase. This paper examines the risk of mortality associated with these impairments in the AGES-RS [22] .
Methods

Study population
Participants of AGES-RS, a population-based study designed to investigate genetic and environmental risk factors of health, disease and disability in older adults, contributed to this analysis. The Icelandic Heart Association (IHA) initiated the Reykjavik Study in 1967, sampling 30,795 people born between 1907 and 1935 and living in Reykjavik, Iceland. From the original cohort, 11,549 were alive in 2002, and a random sample of 5,764 (mean age 77 years, range 67-98 years) participated in AGES-RS. Both vision and hearing examinations were completed by 4,944 (85.8%) participants between 2002 and 2006 [22] . Eighteen participants were excluded due to insufficient vision or hearing data for both eyes and both ears, resulting in 4,926 individuals for the current analysis.
The AGES-RS protocol was approved by the Icelandic National Bioethics Committee (VSN: 00-063), the Icelandic Data Protection Authority and by the Institutional Review Board for the National Institute on Aging, National Institutes of Health, USA. Written informed consent was acquired from all participants.
Vision and hearing examinations
During the baseline eye examination, presenting visual acuity, aided by current corrective lenses, if any, was measured in each eye separately using a table-top Nidek ARK 760A Autorefractor (Nidek Co. Ltd. Tokyo, Japan) with built-in acuity charts. Vision impairment (VI) was defined as a presenting visual acuity of 20/50 or worse in the better eye. Eyes that were blind were not excluded from this analysis.
As with vision, the baseline hearing examination followed a standardized protocol. Pure-tone air-conduction audiometry was conducted in a sound-treated booth using an Interacoustics AD229e microprocessor audiometer (Interacoustics A/S, DK-5610, Assens, Denmark) with standard TDH-39P supra-aural audiometric headphones or E.A.R. tone 3A insert earphones (MEDI, Benicia, CA, USA). Hearing thresholds at frequencies from 0.5 to 8 kHz (0.5, 1, 2, 3, 4, 6 and 8 kHz with a repeat threshold test at 1 kHz for reliability) were measured in each ear. When significant inter-ear differences were found, re-tests were performed using insert earphones to maximise the inter-aural attenuation. 'Moderate or greater' HI was defined as at least 35 decibels (dB) hearing level (HL) for the pure-tone average of four frequencies (0.5, 1, 2 and 4 kHz) in the better ear. This definition corresponds to 'disabling' HI as defined by the Global Burden of Disease Hearing Loss Expert Group [23] , and is the degree of hearing loss for which hearing aids are typically recommended.
Mortality outcome
Mortality status was ascertained by the IHA, with permission of the Icelandic Data Protection Authority, using the complete, adjudicated registry of deaths available from the Icelandic National Roster maintained by Statistics Iceland (http://www. statice.is/Statistics/Population/Births-and-deaths). All-cause and cardiovascular disease (CVD)-related mortality, assigned an ICD10 classification, was available for all deaths recorded through 31 December 2009.
Covariates
Demographic characteristics, health behaviours and medical history were considered as covariates. Education was dichotomized as secondary school graduation and higher versus less than secondary school completion. Smoking status was categorized as never, former or current smoker. The body mass index (BMI) was calculated as weight (kg) divided by height (meters) squared. Hypertension was defined as selfreported history of hypertension, use of antihypertensive drugs or blood pressure ≥140/90 mm Hg. Diabetes mellitus was defined as self-reported history of diabetes, use of glucose-modifying medications, or fasting blood glucose of ≥7.0 mmol/l. Blood samples were drawn after overnight fasting, and total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, glucose and HbA1c were measured in the IHA laboratory. HbA1c levels ≥6.5% were considered elevated. Depressive symptomology was defined as a score of 6 or greater on the 15-item Geriatric Depression Scale. Self-reported health status was dichotomized as good or poor based upon participants response to questions. Cognitive status was determined by professional consensus after reviewing results of cognitive examinations and dichotomized as normal or impaired. Falls during the past 12 months were based on self-report. Walking disability was defined as self-reported difficulty walking or the use of walking aids. A cardiovascular event was defined by report of a myocardial infarction, coronary artery bypass surgery or angioplasty.
Statistical methods
SI was classified into four mutually exclusive groups, no/ mild/unilateral impairment, VI only, HI only or both VI and HI (dual sensory impairment, DSI). Participant characteristics were described using means and standard deviations for continuous variables and percentages and counts for categorical variables. Cox proportional hazards regression, adjusting for potential confounding risk factors, was used to calculate hazard ratios (HRs) with 95% confidence intervals estimating risk of mortality for each impairment group. Since VI and HI increase with advancing age, as does mortality, the participant's age from their baseline examination was used as the time-scale for this analysis. The mortality status of all participants was determined as of 31 December 2009. Risk of mortality by the SI group was computed for participants of the same age, reported as HRs and graphically using Kaplan-Meier plots of survival past baseline examination. Since rates of sensory impairment and mortality differ for men and women, analyses were stratified by sex. Two-sided statistical tests and a 5% significance level were employed. Covariates retained in the analytic models are noted in table footnotes. All analyses were conducted using SAS version 9.3 (SAS Institute, Cary, NC, USA).
Results
Among 4,926 participants, sensory impairment was present in 2,048 (41.6%) participants, of whom 1,250 (25.4%) had HI only, 455 (9.2%) VI only and 343 (7.0%) DSI. Participant characteristics are shown by the impairment group in Table 1 . The mean age of the VI, HI and DSI groups was significantly higher compared with the unimpaired group. Among those with a given impairment, women were more likely than men to have VI (10.5 versus 7.6%, P = 0.10), whereas men were significantly more likely than women to have HI or DSI (29.9 versus 22.0%, P < 0.01 and 8.6 versus 5.7%, P < 0.01, respectively). After adjusting for age and sex, the impaired groups had significantly less education, poorer self-reported health, more depressive symptomology, cognitive impairment, walking disability and higher rates of diabetes.
Between their baseline examination and the end of the follow-up period (median follow-up, 5.3 years, range 3-7 years), 846 (17.2%) individuals died, of which 360 (42.6%) were attributed to CVD. Participants who died were significantly older (79.6 ± 5.7 versus 75.2 ± 4.9 years, P < 0.01) and more likely to be male (51.3 versus 39.8%, P < 0.01), a current or former smoker, report poor health, be cognitively impaired, have diabetes, a history of cancer, angina, CVD or cardiovascular event, higher HDL cholesterol levels and lower total cholesterol levels.
All-cause and CVD-related mortality rates among men and women were significantly different overall (both P < 0.01) and within each sensory impairment group, particularly the DSI group (all-cause: no SI, P < 0.01; VI, P = 0.03; HI, P < 0.01; DSI, P < 0.01; interaction between sex and SI, P = 0.09 and CVD: no SI, P = 0.09; VI, P = 0.08; HI, P = 0.01; DSI, P < 0.01; interaction between sex and SI, P = 0.07). Men were more impaired and more severely impaired in vision and hearing compared with women 1.20 (95% CI: 0.93-1.55)]. In women, associations between HI and all-cause or CVD-related mortality did not reach statistical significance [HRs: 1.23 (95% CI: 0.93-1.64) and 1.44 (95% CI: 0.93-2.22), respectively], and no associations were found between DSI and all-cause or CVD-related mortality.
Among people with HI or DSI, users of hearing aids were, on average, older and had more severe hearing loss compared with people without hearing aids; however, hearing aid users had significantly lower risk of all-cause mortality [HRs: 0.75 (95% CI: 0.58-0.96) for men and 0.67 (95% CI: 0.49-0.92) for women] and, among men, CVD-related mortality risk [HR: 0.63 (95% CI: 0.42-0.92)].
Discussion
This population-based study of community-dwelling older people found sensory impairment to be common and, for men with HI or DSI, associated with all-cause and CVD-related mortality. Whether sensory deficits in men are an indicator of ageing or frailty, physical manifestations resulting in reduced social competence or a reflection of other adverse health states is unclear. The adverse risk in Figure 1 . Kaplan-Meier plots for all-cause and CVD-related mortality rates by type of sensory impairment, stratified by sex and adjusted for age. men could not be attributed to smoking status, self-rated health, cognitive status, falls, walking disability or hearing aid use-all of which were observed to be important mortality risk factors in this study. The increase in mortality risk for men with HI and DSI was the main contributor to the significant overall results for men and women combined. These overall results confirm earlier reports of an association between DSI and increased risk of mortality in a combined sample of men and women [10, 15, 24] . Reuben et al. [5] did not find an association between DSI and mortality, but their sample was younger (aged 55-74 years) and had only 36 participants with DSI compared with the 343 participants ages 67 and older in the present study.
HRs of mortality in women with HI were generally above one, ranging between 1.2 and 1.4, suggesting a possibility of modestly elevated risk. However, these results did not reach statistical significance in this study.
The literature on HI and mortality is sparse [20, 21] . The Blue Mountains Hearing Study [20] reported an association between HI and mortality but concluded that walking disability, cognitive impairment and self-rated health mediated the relationship. In the current analysis, when walking disability, cognitive impairment and self-reported health were taken into account, they did not explain the impact of HI on mortality.
In our study VI was not significantly associated with mortality, consistent with findings from the Blue Mountains Eye Study [19] and the UK [18] . There was a high prevalence of HI in our cohort; however, the number with deficits solely in vision was relatively small. To assess mortality risk among all people with VI, we conducted a secondary analysis combining the VI and DSI groups and again found no association with mortality (results not shown). We cannot explain why our results for VI are different from other studies [25] [26] [27] [28] [29] [30] , but it is possible the older ages in our cohort and other differences in health states experienced by this population may be important.
A Japanese study of older adults aged 65+ years reported sex differences in HI and VI on risk of adverse health outcomes including mortality [12] . After covariate adjustment, increased risk of adverse health outcomes (including death) was reported for men with HI but not for women. No increased risk was reported for VI; DSI was not studied. After removing those using hearing aids, the increase in risk was not altered substantially. Hearing aid use was also considered in the current study. Men and women with hearing aids tended to be older and to have more severe hearing loss compared with others with HI but without hearing aids. However, men and women wearing hearing aids had a decreased risk of dying. We have no firm explanation for this, but we know a hearing aid can reduce the social isolation often experienced by those with HI and possibly the sensorineural stimulation from the hearing aid itself may be important.
The current study has several strengths including results based on a large cohort of older adults, a high participation rate, objective measurements for vision and hearing collected in a standardized manner, availability of a wide array of covariates, and a complete, adjudicated registry of deaths. The study ascertained mortality prospectively and without regard for impairment status. However, some limitations exist. The population is exclusively white, and the health profile of participants in this analysis was measured only once. Thus, increased mortality may result from an undocumented comorbid condition arising after the baseline examination. Finally, although unlikely, the possibility of selection bias, between those who completed the vision and hearing examinations and participants who did not, could have influenced the results. In summary, older men with HI or DSI were at significantly increased risk of all-cause and CVD-related mortality. Use of hearing aids mitigated a portion of this increased risk. Health professionals delivering care to older people need to realize multiple sensory impairments are common and, particularly among men, may predict other adverse health conditions increasing risk of death. Regular assessment of sensory impairment and rehabilitation services targeted for those with decrements in hearing and vision in old age can promote enhanced quality of life, health and longevity.
Key points
• Men with HI and DSI had increased risk of all-cause or CVD-related mortality compared with men without any vision or HI. • Unlike men, women with HI had only slightly higher rates of mortality compared with women without any sensory impairment. Women with DSI were not at higher risk of mortality compared with women without sensory impairments. • VI was not associated with mortality from all-causes or CVD in men or in women.
• Men and women who used hearing aids, although they were older and had more severe hearing loss, had significantly lower mortality risk compared with hearing impaired men and women who did not use hearing aids.
